TITLE

Talking About Investor Financing, Earnings Growth

PUB. DATE
January 2000
SOURCE
Financial Executive;Jan/Feb2000, Vol. 16 Issue 1, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Interview
ABSTRACT
This article presents an interview with Financial Executive Institute President Phil Livingston on biotech companies. He says biotechs need more venture capital than most because of the lengthy time for product development. He also says that credibility is key to attract investors so a firm should make conservative earnings projections and then exceed them.
ACCESSION #
11899423

 

Related Articles

  • Life-Sciences Venture Capital Drought Continues.  // Medical Product Outsourcing;Mar2013, Vol. 11 Issue 2, p24 

    The article focuses on the decline in life-sciences venture capital (VC). It states that the VC funding has declined 14 percent to $6.6 billion in 2012, the lowest level since 1998. It says that the biotechnology sector was unable to keep its momentum from the fall, wherein venture capitalists...

  • Money squeeze. Philippidis, Alex // Westchester County Business Journal;4/28/2003, Vol. 42 Issue 17, p1 

    Reports on the challenges faced by biotechnology companies in securing venture capital in Westchester County, New York. Shift in the focus of investors to later-stage ventures; Impact of the weak stock market on firms contemplating initial public offerings; Decline in the amount of money raised...

  • Venture capital likes biotech.  // New Hampshire Business Review;11/29/2002, Vol. 24 Issue 25, p2B 

    Reports the interest of venture capitalists on biotechnology firms in New England. Decline in venture capital funding; Rise in the funding of medical devices and equipment.

  • The European biotech sector: Could it achieve more? Fazeli, Sam // Journal of Commercial Biotechnology;Oct2005, Vol. 12 Issue 1, p10 

    This article focuses on the European biotech sector. A number of biotech companies in Europe are now in the first or second decade of their lives and there is a recycling of seasoned management into new companies. There is a problem in Europe, however, in that country borders as well as language...

  • Year-end Figures Show Private, Public Investors Staying Away. Robbins-Roth, Cynthia // BioWorld Today;1/26/2009, Vol. 20 Issue 15, p1 

    The author analyzes the financial performance of the biotechnology industry during the economic slowdown in the U.S. She mentions how venture capitalists had a truly terrifying performance in 2008, with a single U.S. biotechnology initial public offering (IPO) completed. According to the author,...

  • What's Happening With Venture Capital, Biotech Funding. Surpin, Beni // San Diego Business Journal;7/07/2003, Vol. 24 Issue 27, p15 

    Focuses on the availability of venture capital funding for biotechnology firms demonstrating strong business plans and management teams in the U.S. Importance of solid management teams; Allure of the biotechnology industry for venture capitalists; Amount of the venture capital raised by the...

  • 3 companies win $21.5M in venture financing. Philippidis, Alex // Westchester County Business Journal;2/17/2003, Vol. 42 Issue 7, p1 

    Reports on the venture capital financing received by some businesses in Westchester County, New York. Difficulty of completing exit strategies; Search of biotechnology and medical products companies for financing; Attraction of investors to the valuations of later-stage firms.

  • Venture capital investing grows from small pool to mainstream asset class.  // Enterprise/Salt Lake City;9/18/2006, Vol. 36 Issue 11, p22 

    The article offers insights on venture capital investing. Venture capitalists foster growth in companies. Depending on their investment strategy, venture capitalists may be generalist or specialist investors. Venture capitalists may invest in the stages of a business life cycle and other...

  • VC Pros and Cons. J. T. B. // Playthings;Oct2007, Vol. 105 Issue 10, p22 

    The article offers information on the advantages and disadvantages of venture capitalism. While the venture capitalist (VC) can provide much needed funding for a toy business, it is not without its drawbacks. Advantages include the availability of capital to find the high growth business;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics